News Flash: Isis Receives $1 Million Milestone Payment from Merck on Initiation of Clinical Development of a Compound Discovered in Collaboration betw
News Flash: Isis Receives $1 Million Milestone Payment from Merck on Initiation of Clinical Development of a Compound Discovered in Collaboration betw
Isis Pharmaceuticals Inc. (NASDAQ: ISIS) a biopharmaceutical company engages in the discovery and development of drugs for the treatment of cardiovascular metabolic inflammatory and ocular diseases as well as cancer in the United States. Shares are up $.07 reaching a high of $11.41 on a volume of over 1 million in the early afternoon trading on Tuesday.